AMA Makes Its Xperteye Solution Compatible With Leading Artificial Intelligence Engines


(MENAFN- GlobeNewsWire - Nasdaq) French English

AMA makes its XpertEye solution compatible with leading A rtificial I ntelligence engines

AMA CORPORATION PLC (AMA), a pioneer in assisted reality solutions and a publisher and integrator of B2B software solutions for smart workplaces, is announcing a technology partnership with Advanced Research In Artificial Neural Networks Inc (ARIANN), a company based in Canada and specialized in research in Artificial Intelligence since 2017.

With this initiative, AMA intends to enable its customers to connect the Artificial Intelligence engines of their choice to its XpertEye secure solutions.

This compatibility will allow its customers, for example, to automate the analysis of data, (images, videos, text, etc.) generated by XpertEye users and to simplify certain key operations such as reporting, or the automatic implementation of procedures.

ARIANN's AI experts are already working closely with AMA's assisted reality experts. The goal of this collaboration is to respond to the growing interest of large corporations in increased productivity associated with Artificial Intelligence. These developments will be integrated into future XperteEye releases.

About AMA

AMA, a software developer and integrator, helps industry and service providers of all sizes, as well as medical establishments, to accelerate their digital transformation, since 2015. AMA's XpertEye suite, addresses a wide range of use cases, from remote diagnostics to inspection, planning and workflow management. Its unique solutions for remote interactive collaboration enable businesses and institutions to increase productivity, speed up resolution times and maximize uptime, while reducing carbon footprint.

With offices in France, Germany, Spain, the United States, China (including Hong Kong) and Japan, AMA has a global presence and works across all time zones to forge close relationships with its clients wherever they are. AMA is listed on Euronext Growth Paris (GB00BNKGZC51 – ALAMA). Learn more at .

About ARIANN

ARIANN, founded by Michel Guillemot and based in Montreal, is specialized in the research and development of Machine Learning and Deep Learning applications, and has been developing custom solutions for various industries since 2017.

Next financial press release

2022 full-year results: April 28, 2023 (before start of trading)

Disclaimer: This press release contains certain non-factual elements, including but not restricted to certain statements concerning its future results and other future events. These statements are based on the current vision and assumptions of AMA Corporation PLC's leadership team. They include various known and unknown uncertainties and risks that could result in material differences in relation to the expected results, profitability and events. In addition, AMA Corporation PLC, its shareholders and its respective affiliates, directors, executives, advisors and employees have not checked the accuracy of and make no representations or warranties concerning the statistical or forward-looking information contained in this press release that is taken from or derived from third-party sources or industry publications. These statistical data and forward-looking information are used in this press release exclusively for information.

Contacts

Investor Relations & Financial Media
Perrine Fromont, CFO - +33 223 441 339 -
Marie Calleux, Calyptus - +33 609 685 538 -
Corporate Media: Esther Duval
+33 689 182 343

Attachment

  • ama_cp_xperteye-ai-collaboration_20230317_en_def v3



Attachments AMA_CP_Xperteye-AI-collaboration_20230317_EN_DEF v3...

MENAFN17032023004107003653ID1105805056


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.